MILLER AINE (SVP, DEV & HEAD OF IRE OFFICE) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/24/2025ACC: 0001415889-25-005351
Officer· SVP, DEV & HEAD OF IRE OFFICE
Since Feb 2026
-11.29K
Net shares
Net seller
$109.1K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
11.29K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−11.29K
Price / share
$9.66
Trade value
$109.11K
% of position
7.5%
2/20/2025
150.56K→139.26K
Total
Net shares
−11.29K
Net value
-$109.11K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 2/20/2025 | F · Tax Withholding | −11.29K | $9.66 | $109.11K | 7.5% | 150.56K | 139.26K |
| Total | −11.29K | -$109.11K | ||||||
Derivative Transactions0
No derivative transactions reported